360 related articles for article (PubMed ID: 16498361)
21. Regulation of breast cancer-associated aromatase promoters.
Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer.
Wang X; Docanto MM; Sasano H; ; Lo C; Simpson ER; Brown KA
Cancer Res; 2015 Feb; 75(4):645-55. PubMed ID: 25634217
[TBL] [Abstract][Full Text] [Related]
23. Aromatase and breast cancer.
Chen S
Front Biosci; 1998 Aug; 3():d922-33. PubMed ID: 9696881
[TBL] [Abstract][Full Text] [Related]
24. Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose.
Rubin GL; Duong JH; Clyne CD; Speed CJ; Murata Y; Gong C; Simpson ER
Endocrinology; 2002 Aug; 143(8):2863-71. PubMed ID: 12130549
[TBL] [Abstract][Full Text] [Related]
25. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
26. Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells.
Martínez-Campa C; González A; Mediavilla MD; Alonso-González C; Alvarez-García V; Sánchez-Barceló EJ; Cos S
Br J Cancer; 2009 Nov; 101(9):1613-9. PubMed ID: 19773750
[TBL] [Abstract][Full Text] [Related]
27. Aromatase in aging women.
Bulun SE; Zeitoun K; Sasano H; Simpson ER
Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
[TBL] [Abstract][Full Text] [Related]
28. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters.
Bulun SE; Sebastian S; Takayama K; Suzuki T; Sasano H; Shozu M
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):219-24. PubMed ID: 14623514
[TBL] [Abstract][Full Text] [Related]
29. Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue.
Sebastian S; Takayama K; Shozu M; Bulun SE
Mol Endocrinol; 2002 Oct; 16(10):2243-54. PubMed ID: 12351690
[TBL] [Abstract][Full Text] [Related]
30. Aromatase and COX-2 expression in human breast cancers.
Brodie AM; Lu Q; Long BJ; Fulton A; Chen T; Macpherson N; DeJong PC; Blankenstein MA; Nortier JW; Slee PH; van de Ven J; van Gorp JM; Elbers JR; Schipper ME; Blijham GH; Thijssen JH
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):41-7. PubMed ID: 11850206
[TBL] [Abstract][Full Text] [Related]
31. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women.
Agarwal VR; Ashanullah CI; Simpson ER; Bulun SE
J Clin Endocrinol Metab; 1997 Jan; 82(1):70-4. PubMed ID: 8989235
[TBL] [Abstract][Full Text] [Related]
32. Sources of estrogen and their importance.
Simpson ER
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):225-30. PubMed ID: 14623515
[TBL] [Abstract][Full Text] [Related]
33. Breast tumor aromatase: functional role and transcriptional regulation.
Chen S; Zhou D; Okubo T; Kao YC; Yang C
Endocr Relat Cancer; 1999 Jun; 6(2):149-56. PubMed ID: 10731103
[TBL] [Abstract][Full Text] [Related]
34. BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.
Lu M; Chen D; Lin Z; Reierstad S; Trauernicht AM; Boyer TG; Bulun SE
J Clin Endocrinol Metab; 2006 Nov; 91(11):4514-9. PubMed ID: 16940443
[TBL] [Abstract][Full Text] [Related]
35. Regulation of aromatase expression in breast cancer tissue.
Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of selective aromatase expression regulators in breast cancer cells.
Su B; Landini S; Davis DD; Brueggemeier RW
J Med Chem; 2007 Apr; 50(7):1635-44. PubMed ID: 17315855
[TBL] [Abstract][Full Text] [Related]
37. Novel sulfonanilide analogues suppress aromatase expression and activity in breast cancer cells independent of COX-2 inhibition.
Su B; Diaz-Cruz ES; Landini S; Brueggemeier RW
J Med Chem; 2006 Feb; 49(4):1413-9. PubMed ID: 16480277
[TBL] [Abstract][Full Text] [Related]
38. Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model.
Heneweer M; Muusse M; Dingemans M; de Jong PC; van den Berg M; Sanderson JT
Toxicol Sci; 2005 Feb; 83(2):257-63. PubMed ID: 15525692
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of intratumoral aromatase messenger RNA levels by docetaxel in human breast cancers.
Miyoshi Y; Kim SJ; Akazawa K; Kamigaki S; Ueda S; Yanagisawa T; Inoue T; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2004 Dec; 10(24):8163-9. PubMed ID: 15623590
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention.
Davies G; Martin LA; Sacks N; Dowsett M
Ann Oncol; 2002 May; 13(5):669-78. PubMed ID: 12075734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
